Citrate Pharmacokinetics in Critically Ill Liver Failure Patients Receiving CRRT

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Citrate ToxicityRegional Citrate AnticoagulationLiver Failure, AcuteLiver Failure, Acute on ChronicPharmacokineticContinuous Renal Replacement Therapy
Interventions
DIAGNOSTIC_TEST

Pharmacokinetic study

"* Start CVVH session with isotonic citrate solution (13.3 mmol/L) as predilution, targeting citrate dose at 3 mmol/L~* Blood samples collection at pre-filter for citrate concentration, blood gas, electrolyte and ionized calcium and magnesium~* In addition, 10 minutes after the end of citrate infusion, blood samples were taken simultaneously from both pre-filter and post-filter to calculate citrate clearance by filter"

Trial Locations (1)

10330

Chulalongkorn university, Bangkok

All Listed Sponsors
lead

Chulalongkorn University

OTHER

NCT04959110 - Citrate Pharmacokinetics in Critically Ill Liver Failure Patients Receiving CRRT | Biotech Hunter | Biotech Hunter